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ABSTRACT
Introduction: Screening for alpha (α) thalassaemia trait (TT) is challenging especially in the presence of iron deficien-
cy (ID). Red blood cell size factor (RSf) is a parameter introduced by Beckman Coulter capable of detecting acute 
and chronic changes to cellular haemoglobin status and iron supply. The research aimed to investigate the clinical 
usefulness of RSf as screening parameter for α TT and the effect of concomitant ID to RSf mean values (m.v) among 
respondents with α TT. Methods: A cross-sectional retrospective laboratory analysis involved 55 respondents’ data 
selected from January 2014 to December 2015 in Pathology Department, Hospital Tuanku Ja’afar Seremban, Negeri 
Sembilan. The significant difference at p <0.05 in the RSf m.v. among respondents with α0 TT, α+ TT, and ID groups 
and the effect concomitant ID to RSf m.v. were determined using statistical test, one-way analysis of variance (ANO-
VA). Results: Significant differences were detected in RSf m.v. i) between α0 TT, α+ TT and ID, F (2, 52) = 18.99, 
p=0.001. ii) between α TT without ID, α TT with ID and ID cohorts for both a) α0 TT [F (2, 33) = 23.77, p=0.001) and 
b) α+ TT [F (2, 28) = 5.37, p=0.011]. iii) between α TT and ID group regardless of the presence of ID for both a) α0 TT 
and b) α+ TT. Conclusion: RSf is a potential screening parameter in evaluating patients with hypochromic microcyto-
sis in identifying possible cases of alpha TT regardless of iron status.
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Iron deficiency is a common cause of microcytic 
anaemia affecting the global population particularly 
children and pregnant women (1). Being microcytic, 
thalassaemia trait (TT) usually resembles iron deficiency 
(ID) with or without anaemia in morphology. However, 
the underlying pathogenesis, treatment and prognosis 
of iron deficiency anaemia (IDA) and thalassaemia are 
entirely different. 
Since the early 1970s, automated full blood count 
(FBC) analysers have been used as initial screening 
tool to discriminate IDA and TT, partly because of 
its economical and practicality (2). Red blood cell 
(RBC) indices including mean corpuscular volume 
(MCV), mean corpuscular haemoglobin (MCH) and 
haemoglobin (Hb) concentration, are useful for 
thalassaemia screening.  Unfortunately, none of these 
parameters is sufficiently reliable to identify the carrier 
status due to highly inaccurate predictors of globin 
genotype. Multiple cut off points have been reported to 
be useful for thalassaemia trait screening between 60-70 
fL for MCV and 19-23 pg for MCH in α-TT detection, 
whereas only slight reduction is usually observed in 
α-TT (3).
Quantification of HbA2 is recognised as an appropriate 
approach for screening and identifying classical beta 
thalassaemia trait. A Hb A2 cut-off level > 4.0% with 
MCV and MCH of <75 fl and <27 pg, respectively, 
were used as benchmark for screening and presumptive 
identification of classical beta thalassaemia carriers 
prior to deoxyribonucleic acid (DNA) studies (4). 
However, normal Hb A2 level does not exclude 
alpha (α) thalassaemia.  A definitive diagnosis of α 
thalassaemia requires DNA analysis (3), however, is 
limited to research laboratories or specialist referral 
centres. Without conclusive diagnosis, some cases may 
be underdiagnosed, and unnecessary iron treatment 
may be given.  Another important reason is to assist in 
the process of genetic counselling to family members 
and couples who are planning to be married.
 
Realising the importance of differentiating the two 
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conditions, many efforts had focused on the new red 
cell parameters. One of these applies reticulocytes 
measurement which is postulated to give a better 
estimate of erythropoietic bone marrow activity. The 
more immature reticulocytes are larger and contain 
more ribonucleid acid (RNA) (5,6). Hence, reticulocyte 
immaturity is directly proportional to the increase in 
light scatter or cell volume.
Red blood cell size factor (RSf) is a new parameter 
on the Beckman Coulter DxH800 that combines the 
information of both mean mature RBC volume and mean 
reticulocyte volume (MRV) by the formula RSf = √MCV x 
MRV.  By considering both dimensions of precursors and 
mature red cells, RSf indirectly reflects the cellular Hb 
content of both cell populations (7). Previous attempted 
studies on RSf were limited and showed variable results.
Urrechaga, who was the pioneer of this subject had 
demonstrated that RSf mean values and standard 
deviation (SD) for patients with IDA was higher than α 
TT even though this study did not particularly intend 
to differentiate TT and IDA. With the cut-off value of 
87.7, receiver operating characteristic (ROC) analysis 
provided area under the curve (AUC) 0.983, 99.4% 
sensitivity and 90.1% specificity for identifying restricted 
erythropoiesis (IDA and α TT) (7).  Interestingly, all α TT 
cases in this study were correctly diagnosed when this 
cut-off value was applied. 
The aim of this study is to determine the significant 
difference in the RSf mean values between the different 
groups of alpha thalassaemia trait and iron deficiency 
anaemia and the effect of iron deficiency to the RSf 
mean values.
MATERIALS AND METHODS
Study design and sampling
This is a retrospective, cross-sectional study conducted 
in the Pathology Department, Hospital Tuanku Ja’afar, 
Seremban (HTJS), Negeri Sembilan from January 2014 
to December 2015. Sample size was calculated using 
sample size calculator (OpenEpi) for comparing two 
means by utilising mean and SD for both TT and ID from 
previous study (7, 8). To achieve the power of study of 
80% and 95% confidence interval, a minimum of 24 
subjects are required.  A total of 72 respondents were 
recruited by random selection from the list of patients 
who were suspected to have α thalassaemia and had 
their samples sent for DNA analysis. 
Inclusion criteria were suspected cases of thalassaemia 
trait from FBC parameters, suspected of Hb Constant 
Spring from high performance liquid chromatography 
(HPLC) and family history of thalassaemia (cascade 
screening). Exclusion criteria were FBC results 
performed by other than Beckman Coulter DXH800 
analyser, absence of iron studies, normal findings of both 
molecular studies for α thalassaemia and biochemical 
tests for iron deficiency, concomitant α thalassaemia or 
any Hb variant, thalassaemia major and thalassaemia 
intermedia (HbH  disease), underlying history of chronic 
illness or inflammation, RSf of > 100 (since RSf mean 
value for healthy individual is 100.9 meanwhile for 
anaemia of chronic disease (ACD) and chronic kidney 
disease (CKD) patients, the RSF mean values are 108.9 
and 110.8, respectively) (7) and any patient age less 
than 6 months old.
Labaratory investigations
Molecular findings from DNA analysis of α globin 
gene were traced manually from the Record Unit, 
Haematopathology Department, Hospital Tuanku Ja’afar 
Seremban.  All information regarding patients’ age, 
gender, ethnicity and other related investigation results 
such as RBC parameters including RSf, serum iron, 
serum total iron binding capacity (TIBC), serum ferritin 
and HPLC findings were obtained from the integrated 
Laboratory Information System.
FBC parameters including RSf were measured by 
Beckman Coulter DXH800. Serum iron and TIBC were 
measured by Siemens Dimension RXL analyser. Serum 
ferritin was quantified by Cantaur XP analyser. HPLC 
on the Beta Thalassaemia Short Program of the Variant 
II (Bio-Rad, Hercules, CA) was the method used for 
identification of variant Hb and HbA2 quantification. 
DNA analysis utilised Multiplex Gap Polymerase Chain 
Reaction (PCR) and Multiplex Amplification Refractory 
Mutation System (ARMS) PCR. 
Socio-demographic characteristics included were 
age, gender and ethnicity. Genetic variants of α 
thalassaemia trait were classified into α+ thalassaemia 
and α0 thalassaemia trait. α+ thalassaemia is divided 
into deletional and non-deletional types. Evidence of 
iron deficiency (ID) is defined by either serum ferritin < 
50 µg/L and/or transferrin saturation: Iron/TIBC X 100 < 
20% (7).
Ethics
Ethical clearance to conduct the study was obtained 
from Medical Research and Ethics Committee, Ministry 
of Health Malaysia and Universiti Putra Malaysia’s 
Research Ethics Committee.
Statistical analysis
Statistical software package IBM SPSS version 23.0 for 
windows was applied for statistical analysis. Descriptive 
analysis was used for describing socio-demographic 
criteria using number and percentage (%). Mean 
and standard deviation (SD) for RSf values were also 
determined for all respondents. Analysis of variance 
using statistical analysis one way-ANOVA followed by 
Post-Hoc test comparison were performed to determine 
significant difference in the RSf mean values among 
respondents between different groups. Group differences 
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were considered statistically significant at p < 0.05.
RESULTS
A total of 72 respondents were initially recruited for the 
study. However, 17 (23.6%) respondents were excluded 
due to incomplete data.
Majority of the subjects were aged more than 15 years 
old (85.5%) and females (87.3%). Malay was the largest 
population (69.1%) followed by Chinese (20%) and 
Indian (10.9%). This finding reflects the ethnic mixture of 
the local area served by the hospital and consistent with 
the ethnic distribution in Malaysia according to 2018 
census (9). Nineteen cases (34.5%) were α+ thalassaemia 
trait and 24 cases (43.6%) were α0 thalassaemia trait. 
The remaining 12 cases (21.8%) had no abnormalities of 
the α gene tested by the same PCR method.
Within the Malay population, majority (31/38) were 
confirmed to have α thalassaemia alleles. The most 
common α globin gene abnormality among Malay 
respondents was the -- SEA (Southeast Asian double 
gene deletion) with 14 (36.8%) cases reported.  Similar 
to Malay population, -- SEA deletion allele was also the 
most common (81.8%) abnormality detected among 
Chinese respondents. In contrast, majority of Indian 
subjects were iron deficient individuals. However, 
within this small Indian population, two cases of α TT 
(one α-3.7 allele and one α-4.2 allele) were identified.
There was a significant difference in the RSf mean values 
between α0 thalassaemia trait, α+ thalassaemia trait and 
iron deficiency group F (2, 52) = 18.99, p=0.001. Table 
I shows Post Hoc comparison results using the Tukey 
HSD test indicated that RSf mean values for both types 
of α TT (α0 and α+ thalassaemia trait were 79.9±4.1 fL and 
83.7±4.4 fL, respectively) were significantly different 
from the ID group (89.4±5.0 fL). 
Effect of iron deficiency on RSf mean values of α TT (α+ 
and α0) was examined separately as depicted in Table 
II and table III . For α0 TT group, significant difference 
was observed in the RSf mean values between the 
three groups (α0 TT without ID, α0 TT with ID and ID 
only) F (2, 33) = 23.77, p=0.001. Table II shows Post 
Hoc comparison results using the Tukey HSD test 
indicated that RSf mean values for both types of α0 TT 
(with and without ID were 77.9 ± 4.4 fL and 81.8±2.8 
fL respectively) were significantly different with the ID 
group (89.4 ± 5.0fL). Lower RSf mean value in α0 TT 
with ID group compared to α0 TT without ID group was 
found. This, however, was not statistically significant.
Table I:. RSf mean value among respondents with α0 thalassaemia trait, 
α+ thalassaemia trait and evidence of iron deficiency 
Variable n Mean (SD) F( df )     p value
RSf 
α0 thalassaemia trait 1,2










      
0.001
1 Significant difference of RSf mean between α0 thalassaemia trait and iron 
deficiency at p= 0.001
2 Significant difference of RSf mean between α+ thalassaemia trait and α0 
thalassaemia trait at p=0.016
3 Significant difference of RSf mean between iron deficiency and α+ thalassaemia 
trait at p=0.003
Table II: Effect of iron deficiency to the RSf mean value of α0 
thalassaemia trait 
Variable n Mean (SD) F( df )  p value
RSf
α0 TT without ID 1
Iron deficiency 1,2







2 3 . 7 7 
(2,33)
      
0.001
1 Significant difference of RSf mean between α0 TT without ID and iron deficiency 
at p = 0.001
2 Significant difference of RSf mean between iron deficiency and α0 TT with ID 
at p=0.001
Table III: Effect of iron deficiency to the RSf mean value of α+ 
thalassaemia trait
Variable n Mean (SD) F( df ) P value
RSf
α+ TT without ID 1
Iron deficiency 1,2








      
0.011
1 Significant difference of RSf mean between α+ TT without ID and iron deficiency 
at p = 0.023
2 Significant difference of RSf mean between iron deficiency and α+ TT with ID 
at p=0.028
Effect of iron deficiency on RSf mean value of α+ 
thalassaemia trait was also observed.   There was a 
significant difference in the RSf mean values for the 
three groups (α+ TT without ID, α+ TT with ID and ID 
only. F (2, 28) = 5.37, p=0.011 as shown by Table III. 
Post Hoc comparison results using the Tukey HSD test 
indicated that the RSf mean values for both types of α+ 
TT (with and without ID were 77.9 ± 5.0 fL and 83.6±3.9 
fL respectively) were significantly different with the ID 
group (89.4±5.0 fL) Lower RSf mean value in α+ TT 
with ID group compared to α+ TT without ID group was 
noted. This however was not statistically significant. 
DISCUSSION
The main aim of this study is to determine whether RSf 
value is able to distinguish α thalassaemia trait from iron 
deficient cases. Demographic profile and the genetic 
variants of respondents in this study did not represent 
28
Malaysian Journal of Medicine and Health Sciences (eISSN 2636-9346)
Mal J Med Health Sci 14(SP3): 25-30, Dec 2018
parameters in such cases may resemble iron deficiency 
but it is already known from previous studies that RBC 
morphology and its indices are not specific enough to 
accurately differentiate these two conditions (12, 18)
To the best of our knowledge, there is absence of 
report on reticulocyte parameter, particularly, RSf 
in characterising the different α gene mutations in 
thalassaemia trait. However, previous work that studied 
erythrocyte parameters suggested that lower MCV and 
MCH values correlated with the severity of the genotype 
findings (13). This is consistent with lower RSf mean 
values obtained in our study among TT with greater 
number of gene deletions. It is particularly important 
to recognize this observation which may be potentially 
useful in the future.
Diagnosis of thalassaemia trait in patients with coexisting 
iron deficiency is even more challenging. It has been 
demonstrated that lower haemoglobin levels and 
reduced red cells indices such as MCV and MCH and near 
normal RBC occurs in such cases (14). Quantification of 
HbA2 may be misleading as iron deficiency can cause 
reduction in HbA2 level and diagnosis of thalassaemia 
trait, particularly beta thalassaemia trait, can be missed 
(15). Several studies have reported evidence of iron 
deficiency among TT patients (14,16). Further reduction 
of Hb level in this group is thought to result from 
lack of nutrients for haemoglobinisation in addition 
to an imbalance in globin chain synthesis. TT and ID 
were previously distinguished by Mentzer index, a 
quantitative method that consider the ratio of MCV and 
RBC. Mentzer index of more than 13 was shown to be 
predictive of ID, meanwhile a value less than 13 favours 
thalassemia trait (17). Unfortunately, this is not practical 
since in most instances the value is borderline and not 
clinically useful. Other methods of different sensitivity 
and specificity have also been described (12, 18).
In this study, RSf mean values of both types (α0 and α+) 
of thalassaemia traits with and without ID displayed 
significantly lower values than those with iron deficiency 
only cohorts. Haematological parameters of mild α 
thalassaemia trait mimic iron deficiency or close to 
normal population This can lead to misdiagnosis of mild 
α thalassaemia trait or unnecessary molecular study 
being done to patient with ID only. The differences 
of RSf values in our findings highlight the potential 
clinical utility of this parameter in the near future. The 
findings in this study suggest that the RSf is capable of 
identifying not only alpha thalassemia trait cases but also 
alpha thalassemia trait individuals with concomitant 
iron deficiency. However, further evaluation of this 
parameter on a larger sample to determine the local cut-
off is required for confirmation.
One of the important limitations in this study is the 
reliability of the research data which used retrospective 
laboratory analysis.  Similar to any laboratory parameters, 
the actual population prevalence of α thalassaemia 
variants in Negeri Sembilan. This is because the 
population sampling was purposive with tight inclusion 
and exclusion criteria. This led to nearly 24% drop outs 
from a total number of 72 randomly selected cases 
resulting in a final total of 55 respondents. Presence of 
concomitant Hb E detected from HPLC was also one 
of the common reasons of exclusion. A few subjects 
of infants less than six months old were also excluded 
from the study to minimise the effect of higher MCV, 
especially in newborns.
Significant differences in RSf mean values (p<0.05) were 
detected in this study when groups with thalassaemia 
trait (α0 and α+ thalassaemia trait) were compared 
with iron deficiency patients. These findings support 
previous evidence that has recommended RSf as a useful 
parameter in differentiating thalassaemia traits and IDA 
patients (10). In this study, Ng et al., 2015 showed that 
IDA group had significantly higher RSf values than the 
TT group among Hong Kong population. However, 
due to significant overlap between the values in two 
groups, the performance of this single parameter is still 
questionable. One of the major limitations of Ng’s study 
was the method used in classifying α TT, considered 
to be less reliable. Diagnosis of α TT in his study were 
made by occurrence of very occasional (<0.1%) HbH 
inclusion bodies with no molecular confirmation (10). 
In contrast, diagnosis of α TT in our study was confirmed 
by DNA analysis.
RSf combines the information of both mean mature 
RBC volume and mean reticulocyte volume (MRV) by 
the formula RSf = √MCV x MRV. MRV is a real time 
measurement of the cell dimension of recently produced 
erythrocytes i.e. within the period of less than 48 hours 
and represents iron availability during haemoglobin 
synthesis.  MCV is a measurement of the average size 
or volume of mature red blood cells. Adding a square 
root in the formula will average out the volume of both 
populations of erythrocytes.
RSf in IDA patients are postulated to be higher than 
thalassaemia trait individuals because of the presence 
of both normocytic and microcytic RBC population in 
iron-deficient states reflecting a progressive decrease in 
iron stores during continuous marrow erythropoiesis. 
In contrast, lower RSf mean values in thalassaemia 
traits are the result of constantly uniform population of 
microcytic erythrocytes due to globin gene mutation but 
normal iron stores (11).
Interestingly, RSf mean value for α0 TT in this study 
was also significantly lower than α+ thalassaemia trait 
individuals (p=0.016). Thalassaemia trait individuals with 
two α gene deletions may be wrongly suspected of iron 
deficiency particularly when the levels of haemoglobin 
and RBC were mildly reduced to borderline low-normal 
but showed lower MCV and MCH values. The RBC 
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RSf values may be affected by the preanalytical factors 
involved during sample collection, sample storage, time 
frame from sample collection to sample processing and 
so forth. We therefore attempted to minimise the storage 
effect by excluding cases that have reported storage 
changes on the red blood cell morphology.
Another limitation is the lack of respondents’ clinical 
data obtained from the request forms that might 
affect RSf values. Relevant clinical information is very 
important for RSf interpretation such as history of acute 
or chronic inflammation, pregnancy status, medication 
history and vitamin B12 and folate status.  Although iron 
deficiency was defined using biochemical test results 
(ferritin and transferrin saturation), this however can be 
argued whether the results were captured at latent phase 
or whether the patients were on treatment. 
CONCLUSION
The present study observed significant difference in RSf 
mean values (p<0.05) between thalassaemia trait (α0 and 
α+ thalassaemia trait) and iron deficiency cohorts. RSf 
may also be useful to suggest the presence of globin gene 
mutation despite presence of biochemical evidence of 
concomitant iron deficiency. Thus, RSf is a potential 
parameter to be used as a first line screening tool in 
identifying likelihood cases of mild alpha TT which 
have either normal red blood cell indices or indices that 
mimic iron deficiency.  These findings require validation 
with a larger subject population, using a prospective 
study design to achieve better selection criteria.
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